BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28455922)

  • 41. The effect of ultrafiltration with cardiopulmonary bypass on the removal of dabigatran from the circulation of adult pigs.
    DeNino WF; Carter CB; Sievert A; Goss A; Toole JM; Mukherjee R; Uber WE
    Perfusion; 2016 Jul; 31(5):424-30. PubMed ID: 26519741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of automated blood volume control on the incidence of intra-dialysis hypotension].
    Germin Petrović D
    Acta Med Croatica; 2003; 57(1):17-22. PubMed ID: 12876857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can a decreasing ultrafiltration profile affect the dialytic dose administered?
    Ramunni A; Brescia P; Ranieri G; Ria R; Coratelli P
    Ther Apher Dial; 2006 Oct; 10(5):463-6. PubMed ID: 17096702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome predictors of ultrafiltration in patients with refractory congestive heart failure and renal failure.
    Ramos R; Salem BI; DePawlikowski MP; Tariq M; Haikal M; Pohlman T; Mennes P
    Angiology; 1996 May; 47(5):447-54. PubMed ID: 8644941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients.
    Lin X; Lin A; Ni Z; Yao Q; Zhang W; Yan Y; Fang W; Gu A; Axelsson J; Qian J
    Nephrol Dial Transplant; 2010 Jul; 25(7):2322-7. PubMed ID: 20118483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Which fluid space is affected by ultrafiltration during hemodiafiltration?
    Tapolyai MB; Faludi M; Fülöp T; Dossabhoy NR; Szombathelyi A; Berta K
    Hemodial Int; 2014 Apr; 18(2):384-90. PubMed ID: 24438545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of "refilling types" by continuous blood volume monitoring during hemodialysis.
    Röckel A; Abdelhamid S; Fiegel P; Menth M; Walb D; Schneditz D
    Kidney Int Suppl; 1993 Jun; 41():S67-9. PubMed ID: 8320948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Influence of Plasma Albumin Concentration on the Analysis Methodology of Free Valproic Acid by Ultrafiltration and Its Application to Therapeutic Drug Monitoring.
    Zhang ZQ; Dong WC; Yang XL; Zhang JF; Jiang XH; Jing SJ; Yang HL; Jiang Y
    Ther Drug Monit; 2015 Dec; 37(6):776-82. PubMed ID: 26035137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The adjustment of post-dialysis dry weight based on non-invasive measurements in children.
    Sönmez F; Mir S; Ozyürek AR; Cura A
    Nephrol Dial Transplant; 1996 Aug; 11(8):1564-7. PubMed ID: 8856212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Merits and limitations of continuous blood volume monitoring during haemodialysis. Summary of the EDTNA/ERCA Journal Club discussion: Winter 2005.
    Lindley EJ
    EDTNA ERCA J; 2006; 32(2):108-16. PubMed ID: 16898105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.
    Davies SJ; Bryan J; Phillips L; Russell GI
    Nephrol Dial Transplant; 1996 Mar; 11(3):498-506. PubMed ID: 8671821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparisons of the peritoneal equilibration test and ultrafiltration in patients with and without diabetes mellitus on continuous ambulatory peritoneal dialysis.
    Chou MY; Kao MT; Lai MN; Chung SY
    Am J Nephrol; 2006; 26(1):87-90. PubMed ID: 16543711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Continuous measurement of blood volume changes in hemodialysis using an ultrasound method].
    Roob JM; Schneditz D; Haas GM; Horina JH; Pogglitsch H
    Wien Klin Wochenschr; 1990 Mar; 102(5):131-6. PubMed ID: 2181783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utilization of in vivo ultrafiltration in biomedical research and clinical applications.
    Leegsma-Vogt G; Janle E; Ash SR; Venema K; Korf J
    Life Sci; 2003 Sep; 73(16):2005-18. PubMed ID: 12899925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Finding the right blood type.
    Czajka C
    Science; 2017 Mar; 355(6330):1169-1170. PubMed ID: 28302832
    [No Abstract]   [Full Text] [Related]  

  • 56. Soft Target Weight: Theory and Simulation of a Novel Haemodialysis Protocol Which Reduces Excessive Ultrafiltration.
    Ashby D; Corbett R; Duncan N
    Nephron; 2022; 146(2):160-166. PubMed ID: 34784606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous Blood Volume Monitoring and Ultrafiltration Control.
    Lopot F; Nejedlý B; Sulková S
    Hemodial Int; 2000 Jan; 4(1):8-14. PubMed ID: 28455922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computational analysis of blood volume dynamics during hemodialysis.
    Lopot F; Kotyk P
    Int J Artif Organs; 1997 Feb; 20(2):91-5. PubMed ID: 9093886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hemodynamic effect of different ultrafiltration rates in patients with cardiac failure and patients without cardiac failure: comparison between isolated ultrafiltration and ultrafiltration with dialysis.
    van der Sande FM; Mulder AW; Hoorntje SJ; Peels KH; van Kuijk WH; Kooman JP; Leunissen KM
    Clin Nephrol; 1998 Nov; 50(5):301-8. PubMed ID: 9840318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemodynamic response to fluid withdrawal in overhydrated patients treated with intermittent ultrafiltration and slow continuous ultrafiltration: role of blood volume monitoring.
    Ronco C; Bellomo R; Ricci Z
    Cardiology; 2001; 96(3-4):196-201. PubMed ID: 11805387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.